105
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Network Analysis and Ligand-Based Pharmacophore Modeling for Discovery of Small Molecule Against Glioblastoma Multiforme

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1203-1218 | Received 10 May 2022, Accepted 05 Jul 2022, Published online: 01 Aug 2022

References

  • Anjum K , ShaguftaBI , AbbasSQet al. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: a review. Biomed. Pharmacother.92, 681–689 (2017).
  • Harilal S , JoseJ , ParambiDGTet al. Revisiting the blood–brain barrier: a hard nut to crack in the transportation of drug molecules. Brain Res. Bull.160, 121–140 (2020).
  • Luo F , GuJ , ChenL , XuX. Systems pharmacology strategies for anticancer drug discovery based on natural products. Mol. Biosyst.10(7), 1912–1917 (2014).
  • Shannon P , MarkielA , OzierOet al. Cytoscape: a software environment for integrated models. Genome Res.13(22), 426 (1971).
  • Abbruzzese C , MatteoniS , SignoreMet al. Drug repurposing for the treatment of glioblastoma multiforme. J. Exp. Clin. Cancer Res.36(1), 1–11 (2017).
  • Huang D , ZhuX , TangCet al. 3D QSAR pharmacophore modeling for c-Met kinase inhibitors. Med. Chem.8(6), 1117–1125 (2012).
  • Benny S , MishraR , ManojkumarMK , AneeshTP. From Warburg effect to reverse Warburg effect; the new horizons of anti-cancer therapy. Med. Hypotheses144, 110216 (2020).
  • Torrisi F , VicarioN , SpitaleFMet al. The role of hypoxia and c-Src tyrosine kinase in glioblastoma invasiveness and radioresistance. Cancers (Basel)12(10), 1–18 (2020).
  • Roskoski R . Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors. Pharmacol. Res.94, 9–25 (2015).
  • Menon SMP , ElengoeA. Evaluation of the role of kras gene in colon cancer pathway using string and Cytoscape software. Biomed. Res. Ther.7(6), 3835–3842 (2020).
  • Kim M , KimYB. A network-based pharmacology study of active compounds and targets of Fritillaria thunbergii against influenza. Comput. Biol. Chem.89, 107375 (2020).
  • Chin CH , ChenSH , WuHH , HoCW , KoMT , LinCY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol.8(4), 1–7 (2014).
  • Maere S , HeymansK , KuiperM. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics21(16), 3448–3449 (2005).
  • Kanehisa M . Toward understanding the origin and evolution of cellular organisms. Protein Sci.28(11), 1947–1951 (2019).
  • Kanehisa Minoru GS . KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res.28(1), 27–30 (2000).
  • Vishal PK , OhJM , KhamesAet al. Trimethoxylated halogenated chalcones as dual inhibitors of MAO-B and BACE-1 for the treatment of neurodegenerative disorders. Pharmaceutics13(6), 850 (2021).
  • Sukumaran S , MeghnaM , SnehaS , ArjunB. In silico analysis of acridone against TNF-α and PDE4 targets for the treatment of psoriasis. Int. J. Res. Pharm. Sci.11(SPL4), 1251–1259 (2020).
  • Pal S , KumarV , KunduBet al. Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors. Comput. Struct. Biotechnol. J.17, 291–310 (2019).
  • Kurogi Y , GunerO. Pharmacophore modeling and three-dimensional database searching for drug design using Catalyst. Curr. Med. Chem.8(9), 1035–1055 (2012).
  • Rampogu S , BaekA , SonMet al. Discovery of lonafarnib-like compounds: pharmacophore modeling and molecular dynamics studies. ACS Omega5(4), 1773–1781 (2020).
  • Sobhy MK , MowafyS , LasheenDS , FaragNA , AbouzidKAM. 3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: design, synthesis and biological evaluation. Bioorg. Chem.89, 102988 (2019).
  • Gupta AK , BhuniaSS , BalaramnavarVM , SaxenaAK. Pharmacophore modelling, molecular docking and virtual screening for EGFR (HER 1) tyrosine kinase inhibitors. SAR QSAR Environ. Res.22(3), 239–263 (2011).
  • Jiang Y , GaoH. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease. Phytomedicine54, 278–290 (2019).
  • Lu S , WuJW , LiuHet al. The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies. J. Biomed. Sci.18(1), 8 (2011).
  • Rampogu S , SonM , BaekAet al. Targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches. Comput. Biol. Chem.74, 327–338 (2018).
  • Al-Sha'er MA , BasheerHA , TahaMO. Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores. Mol. Divers. doi: 10.1007/s11030-022-10434-4 (2022) ( Epub ahead of print).
  • Ganesan MS , RajaKK , NarasimhanK , MurugesanS , KumarBK. Design, synthesis, α-amylase inhibition and in silico docking study of novel quinoline bearing proline derivatives. J. Mol. Struct.1208, 127873 (2020).
  • Katari SK , NatarajanP , SwargamS , KanipakamH , PasalaC , UmamaheswariA. Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations docking and molecular dynamics simulations. J. Recept. Signal Transduct. Res.36(6), 558–571 (2016).
  • Safna Hussan KP , ShahinThayyil M , RajanVK , MuraleedharanK. DFT studies on global parameters, antioxidant mechanism and molecular docking of amlodipine besylate. Comput. Biol. Chem.80, 46–53 (2019).
  • Panwar U , SinghSK. In silico virtual screening of potent inhibitor to hamper the interaction between HIV-1 integrase and LEDGF/p75 interaction using E-pharmacophore modeling, molecular docking, and dynamics simulations. Comput. Biol. Chem.93, 107509 (2021).
  • Singh IA . Identification and screening of novel anti-cancer compound for aurora kinase A from chemical database. Research Square.(v1), 1–22 (2021).
  • Friesner RA , BanksJL , MurphyRBet al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem.47(7), 1739–1749 (2004).
  • Mishra VR , GhanavatkarCW , QureshiSI. Design, synthesis, antimicrobial activity and computational studies of novel azo linked substituted benzimidazole, benzoxazole and benzothiazole derivatives. Comput. Biol. Chem.78, 330–337 (2019).
  • Bhaskar V , NambooriK , PappachenLK. In silico discovery of novel ligands for anti-tubercular targets using computer aided drug design. Res. J. Pharm. Technol.12(11), 5646–5650 (2019).
  • Raghi KR , SherinDR , SaumyaMJ , ArunPS , SobhaVN , ManojkumarTK. Computational study of molecular electrostatic potential, docking and dynamics simulations of gallic acid derivatives as ABL inhibitors. Comput. Biol. Chem.74, 239–246 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.